BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/25/2023 6:43:29 AM | Browse: 423 | Download: 1005
 |
Received |
|
2023-04-27 18:25 |
 |
Peer-Review Started |
|
2023-04-27 18:27 |
 |
First Decision by Editorial Office Director |
|
2023-05-19 07:23 |
 |
Return for Revision |
|
2023-05-19 07:23 |
 |
Revised |
|
2023-06-11 15:07 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2023-06-27 02:52 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2023-06-27 09:24 |
 |
Articles in Press |
|
2023-06-27 09:24 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-07-18 06:04 |
 |
Publish the Manuscript Online |
|
2023-07-25 06:43 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
Could extracellular vesicles derived from mesenchymal stem cells be a potential therapy for acute pancreatitis-induced cardiac injury?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Long-Fei Pan, Ze-Qun Niu, Song Ren, Hong-Hong Pei, Yan-Xia Gao, Hui Feng, Jiang-Li Sun and Zheng-Liang Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Basic Research Program of Shaanxi |
2021JM-284 |
| Health research projects of Shaanxi Province |
2021A010 |
| Science and Technology Planning Project of Xi’an |
22YXYJ0111 |
|
| Corresponding Author |
Long-Fei Pan, MD, Associate Chief Physician, Associate Professor, Emergency Department, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xincheng District, Xi'an 710004, Shaanxi Province, China. panlonf@yeah.net |
| Key Words |
Acute pancreatitis; Cardiac injury; Mesenchymal stem cells; Extracellular vesicles; Inflammation; Therapeutic strategies |
| Core Tip |
Acute pancreatitis (AP) often causes cardiac injury, leading to poor prognosis. Mesenchymal stem cells (MSCs) and their extracellular vesicles (EVs) possess anti-inflammatory properties and have been studied as a potential therapy for inflammatory diseases. Although preclinical studies on the use of MSCs-EVs for AP-induced cardiac injury are lacking, research has demonstrated their positive effects in various inflammatory diseases such as sepsis-induced cardiac injury and cardiovascular diseases. Therefore, MSCs-EVs may represent a promising strategy for treating AP-induced cardiac injury. |
| Publish Date |
2023-07-25 06:43 |
| Citation |
Pan LF, Niu ZQ, Ren S, Pei HH, Gao YX, Feng H, Sun JL, Zhang ZL. Could extracellular vesicles derived from mesenchymal stem cells be a potential therapy for acute pancreatitis-induced cardiac injury? World J Stem Cells 2023; 15(7): 654-664 |
| URL |
https://www.wjgnet.com/1948-0210/full/v15/i7/654.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v15.i7.654 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.